October 7, 2024

DNA Microarray Market Will be USD 5.04 Billion By 2032

The DNA microarray market size was valued at USD 2.28 billion in 2023 and is expected to reach USD 5.04 billion by 2032, poised to grow at a CAGR of 9.20% from 2023 to 2032.

Key Takeaways

  • North America led the global market with the highest market share of 36% in 2022.
  • Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
  • By type, the oligonucleotide DNA microarrays segment had the major market revenue share of 45% in 2022.
  • By type, the complementary DNA microarrays segment is anticipated to grow a noteworthy CAGR of 10.1% during the projected period.
  • By application, the gene expression analysis segment contributed more than 46% of revenue share in 2022.
  • By end-user, the academic & research institutes segment has held the major market share of 37% in 2022.
  • By end-user, the diagnostic centers segment is predicted to grow at the fastest CAGR over the projected period.

DNA Microarray Market Statistics 2023 To 2032

The DNA Microarray Market has witnessed substantial growth in recent years, driven by advancements in genomics and personalized medicine. DNA microarrays play a pivotal role in analyzing the expression of thousands of genes simultaneously, facilitating comprehensive insights into genetic variations. This technology has found widespread applications in research, diagnostics, and drug development, contributing to its escalating global demand.

Get a Sample: https://www.precedenceresearch.com/sample/3648

Growth Factors

Several factors contribute to the growth of the DNA Microarray Market. The increasing prevalence of genetic disorders, coupled with the rising adoption of precision medicine, has fueled the demand for DNA microarray technologies. Technological advancements, such as the development of high-throughput microarray platforms, have enhanced the efficiency and accuracy of genetic analysis, further propelling market growth. Additionally, the expanding applications of DNA microarrays in fields like oncology and pharmacogenomics contribute significantly to the market’s upward trajectory.

Region Snapshot 

The DNA Microarray Market exhibits a robust global presence, with North America leading in terms of market share. The region’s dominance is attributed to a well-established healthcare infrastructure, extensive research and development activities, and a high prevalence of genetic disorders. Europe follows closely, driven by increasing investments in genomics research. Asia-Pacific showcases immense growth potential, with a burgeoning healthcare sector and rising awareness about personalized medicine.

DNA Microarray Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 9.20%
Market Size in 2023 USD 2.28 Billion
Market Size by 2032 USD 5.04 Billion
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Type, By Application, and By End-user
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

DNA Microarray Market Dynamics

Driver:

A key driver of the DNA Microarray Market is the surging demand for personalized medicine. As healthcare shifts towards more individualized treatment approaches, DNA microarrays enable precise identification of genetic variations, aiding in tailoring therapeutic interventions. The continuous advancements in bioinformatics and data analysis tools further amplify the market’s growth, providing researchers and clinicians with powerful tools for genetic exploration.

Opportunities:

Opportunities abound in the DNA Microarray Market, particularly with the increasing focus on companion diagnostics and the integration of microarray technologies in clinical practice. Moreover, the expanding scope of applications in fields like agricultural genomics and forensic sciences opens new avenues for market players. Strategic collaborations and partnerships for technology development and market expansion present lucrative opportunities in this dynamic landscape.

Challenges:

Despite its growth, the DNA Microarray Market faces challenges, including the high cost associated with advanced microarray technologies. The complexity of data interpretation and the need for skilled professionals also pose hurdles. Moreover, ethical concerns related to the use of genetic information and the potential for data breaches are challenges that industry stakeholders must address for sustained growth.

Competitive Landscape:

The DNA Microarray Market is characterized by intense competition among key players. Companies are actively engaged in research and development to introduce innovative products and gain a competitive edge. Key players often focus on strategic collaborations, mergers, and acquisitions to expand their product portfolios and enhance their market presence. Some prominent players in the market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, each contributing significantly to the market’s competitive dynamics.

Read Also: Web 3.0 Market Size To Worth USD 65.78 Billion By 2032

Recent Developments

  • In 2020, Thermo Fisher Scientific Inc. partnered with QIAGEN N.V. to expand its offering of molecular diagnostics solutions, including DNA microarrays.
  • In 2018, Agilent announced a strategic scientific collaboration with the University of Southern California (USC) to support innovative biomedical science and engineering research initiatives, fostering transformational advancements in these fields.
  • In 2017, Bio-Rad Laboratories, Inc. acquired RainDance Technologies, Inc., a company specializing in droplet-based microfluidics solutions for genomics research, complementing its microarray offerings.

DNA Microarray Market Companies

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Roche Diagnostics
  • Qiagen N.V.
  • Oxford Gene Technology (OGT)
  • Applied Microarrays, Inc.
  • Eurofins Genomics LLC
  • LC Sciences
  • Microarrays Inc.
  • Arrayit Corporation
  • BioCat GmbH
  • Savyon Diagnostics Ltd.

Segments Covered in the Report

By Type

  • Complementary DNA Microarrays
  • Oligonucleotide DNA Microarrays
  • Others

By Application

  • Gene Expression Analysis
  • Genotyping
  • Others

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Centers
  • Hospitals and Clinics
  • Academic and Research Institute
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Microarray Market 

5.1. COVID-19 Landscape: DNA Microarray Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Microarray Market, By Type

8.1. DNA Microarray Market, by Type, 2023-2032

8.1.1 Complementary DNA Microarrays

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Oligonucleotide DNA Microarrays

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global DNA Microarray Market, By Application

9.1. DNA Microarray Market, by Application, 2023-2032

9.1.1. Gene Expression Analysis

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Genotyping

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global DNA Microarray Market, By End-user 

10.1. DNA Microarray Market, by End-user, 2023-2032

10.1.1. Pharmaceutical and Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Hospitals and Clinics

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Academic and Research Institute

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global DNA Microarray Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End-user (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-user (2020-2032)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Illumina, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. PerkinElmer, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Roche Diagnostics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Qiagen N.V.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Oxford Gene Technology (OGT)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Applied Microarrays, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Eurofins Genomics LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/


Leave a Reply

Your email address will not be published. Required fields are marked *